BASE life science A/S Financials, key figures and credit report
Gross profit 235 554.7 kDKK FY 2024 -0.5% vs 2023
EBIT -45 276.4 kDKK FY 2024 +44.9% vs 2023
Net debt -28 744.2 kDKK FY 2024 -133% vs 2023
Quick ratio 1.9 FY 2024 +0.6 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 110 194.51 | 158 135.50 | 202 294.94 | 236 774.34 | 235 554.66 |
| Employee benefit expenses | -89 329.66 | - 125 405.77 | - 223 849.71 | - 315 093.35 | - 277 834.77 |
| Total depreciation | - 138.38 | - 914.79 | -2 900.36 | -3 784.75 | -2 996.34 |
| EBIT | 20 726.47 | 31 814.93 | -24 455.13 | -82 103.76 | -45 276.45 |
| Other financial income | 26.51 | 113.71 | 171.04 | 3 158.73 | 2 197.65 |
| Other financial expenses | - 277.90 | - 460.66 | - 722.70 | -6 849.83 | -8 728.56 |
| Pre-tax profit | 20 475.09 | 31 467.98 | -25 006.79 | -85 794.86 | -51 807.35 |
| Income taxes | -3 198.04 | -7 273.18 | -6 217.50 | -2 512.27 | - 351.17 |
| Net earnings | 17 277.05 | 24 194.81 | -31 224.29 | -88 307.13 | -52 158.52 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 4 123.26 | 4 839.42 | 3 859.75 | 2 894.81 | 1 929.88 |
| Intangible rights | 83.07 | 65.27 | 47.47 | ||
| Intangible assets total | 4 123.26 | 4 839.42 | 3 942.82 | 2 960.08 | 1 977.34 |
| Machinery and equipment | 470.34 | 3 097.71 | 3 999.05 | 3 118.10 | 7 296.41 |
| Tangible assets total | 470.34 | 3 097.71 | 3 999.05 | 3 118.10 | 7 296.41 |
| Investments total | 468.92 | 925.20 | 1 051.81 | 1 689.26 | 2 164.41 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 33 474.78 | 72 812.58 | 41 975.38 | 59 841.21 | 35 075.56 |
| Current owed by particip. interest comp. | 1 284.33 | 7 838.28 | 8 850.85 | ||
| Prepayments and accrued income | 409.69 | 4 135.83 | 2 571.55 | 4 205.23 | 2 515.58 |
| Current other receivables | 8 173.28 | 10 797.66 | 52 603.74 | 54 618.13 | 33 950.11 |
| Current deferred tax assets | 921.39 | 2 482.46 | 1 362.17 | ||
| Short term receivables total | 42 979.14 | 87 746.07 | 98 434.99 | 128 985.31 | 81 754.26 |
| Cash and bank deposits | 9 347.61 | 3 676.31 | 12 229.01 | 18 681.48 | 79 111.68 |
| Cash and cash equivalents | 9 347.61 | 3 676.31 | 12 229.01 | 18 681.48 | 79 111.68 |
| Balance sheet total (assets) | 57 389.26 | 100 284.71 | 119 657.68 | 155 434.23 | 172 304.10 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 597.40 | 597.40 | 600.40 |
| Share premium account | 164 123.00 | ||||
| Shares repurchased | 2 109.00 | ||||
| Other reserves | 4 123.26 | 3 763.26 | 3 010.61 | 2 257.95 | 1 505.30 |
| Retained earnings | 4 804.80 | 21 657.20 | 49 112.51 | 18 853.17 | -68 489.02 |
| Profit of the financial year | 17 277.05 | 24 194.81 | -31 224.29 | -88 307.13 | -52 158.52 |
| Shareholders equity total | 28 914.10 | 50 215.27 | 21 496.23 | -66 598.61 | 45 581.16 |
| Provisions | 1 250.00 | 1 265.27 | 997.93 | 802.66 | 395.14 |
| Non-current loans from credit institutions | 1 923.29 | ||||
| Non-current owed to group member | 97 379.54 | 36 819.54 | |||
| Non-current liabilities total | 1 923.29 | 97 379.54 | 36 819.54 | ||
| Current loans from credit institutions | 110.68 | 3 063.09 | 347.65 | 558.51 | 503.57 |
| Advances received | 256.35 | 947.68 | 2 407.56 | 7 817.50 | 3 223.32 |
| Current trade creditors | 2 041.21 | 9 027.60 | 3 895.98 | 9 372.69 | 4 392.98 |
| Current owed to participating | 513.06 | 513.06 | |||
| Current owed to group member | 1 254.01 | 7 959.78 | 13 044.34 | ||
| Short-term deferred tax liabilities | 3 451.76 | 9 089.48 | 10 468.09 | 3 147.66 | 1 767.05 |
| Other non-interest bearing current liabilities | 16 743.40 | 26 163.27 | 78 790.23 | 94 994.49 | 66 577.01 |
| Accruals and deferred income | 2 185.41 | ||||
| Current liabilities total | 25 301.87 | 48 804.18 | 97 163.52 | 123 850.64 | 89 508.26 |
| Balance sheet total (liabilities) | 57 389.26 | 100 284.71 | 119 657.68 | 155 434.23 | 172 304.10 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 The current price above includes VAT and is paid securely through Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated